Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia

Isa Okajima, Masaki Nakamura, Shingo Nishida, Akira Usui, Ken ichi Hayashida, Meri Kanno, Shun Nakajima, Yuichi Inoue

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

This study aimed to determine whether (1) cognitive behavioural therapy with behavioural analysis for insomnia (CBTi-BA) is more effective for insomnia and co-morbid depressive symptoms than treatment as usual (TAU) and (2) whether CBTi-BA promotes earlier reduction of the daily dose of hypnotic medication in chronic insomnia resistant to pharmacological treatment. A total of 63 patients with chronic insomnia aged 20-77 years who already received hypnotic medication regularly were assigned to two interventions: combined therapy or TAU alone. The subjects provided demographic information and completed self-rating scales for insomnia and depressive symptoms. After treatment, the combined therapy group showed significant decreases in the symptoms of both insomnia and depression and significant reductions in the daily dose of hypnotic medication compared with the group receiving TAU alone. In the combined therapy group, 71% of the participants reported a reduction in insomnia to normal levels and 79% succeeded in decreasing the daily dose of hypnotics to 50% or less of the baseline dose. These results revealed that CBTi-BA can reduce insomnia and depressive symptoms as well as the daily dose of hypnotic medication in patients with chronic insomnia resistant to pharmacological treatment.

Original languageEnglish
Pages (from-to)515-521
Number of pages7
JournalPsychiatry Research
Volume210
Issue number2
DOIs
Publication statusPublished - 2013 Dec 15
Externally publishedYes

Fingerprint

Sleep Initiation and Maintenance Disorders
Cognitive Therapy
Pharmacology
Hypnotics and Sedatives
Therapeutics
Depression
Group Psychotherapy
Demography

Keywords

  • Behavioural analysis
  • Cognitive behavioural therapy
  • Hypnotics
  • Insomnia
  • Treatment-resistant

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry
  • Medicine(all)

Cite this

Okajima, I., Nakamura, M., Nishida, S., Usui, A., Hayashida, K. I., Kanno, M., ... Inoue, Y. (2013). Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia. Psychiatry Research, 210(2), 515-521. https://doi.org/10.1016/j.psychres.2013.06.028

Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia. / Okajima, Isa; Nakamura, Masaki; Nishida, Shingo; Usui, Akira; Hayashida, Ken ichi; Kanno, Meri; Nakajima, Shun; Inoue, Yuichi.

In: Psychiatry Research, Vol. 210, No. 2, 15.12.2013, p. 515-521.

Research output: Contribution to journalArticle

Okajima, I, Nakamura, M, Nishida, S, Usui, A, Hayashida, KI, Kanno, M, Nakajima, S & Inoue, Y 2013, 'Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia', Psychiatry Research, vol. 210, no. 2, pp. 515-521. https://doi.org/10.1016/j.psychres.2013.06.028
Okajima, Isa ; Nakamura, Masaki ; Nishida, Shingo ; Usui, Akira ; Hayashida, Ken ichi ; Kanno, Meri ; Nakajima, Shun ; Inoue, Yuichi. / Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia. In: Psychiatry Research. 2013 ; Vol. 210, No. 2. pp. 515-521.
@article{6ea146c0536846c7b7ff7dc622ba8bf2,
title = "Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia",
abstract = "This study aimed to determine whether (1) cognitive behavioural therapy with behavioural analysis for insomnia (CBTi-BA) is more effective for insomnia and co-morbid depressive symptoms than treatment as usual (TAU) and (2) whether CBTi-BA promotes earlier reduction of the daily dose of hypnotic medication in chronic insomnia resistant to pharmacological treatment. A total of 63 patients with chronic insomnia aged 20-77 years who already received hypnotic medication regularly were assigned to two interventions: combined therapy or TAU alone. The subjects provided demographic information and completed self-rating scales for insomnia and depressive symptoms. After treatment, the combined therapy group showed significant decreases in the symptoms of both insomnia and depression and significant reductions in the daily dose of hypnotic medication compared with the group receiving TAU alone. In the combined therapy group, 71{\%} of the participants reported a reduction in insomnia to normal levels and 79{\%} succeeded in decreasing the daily dose of hypnotics to 50{\%} or less of the baseline dose. These results revealed that CBTi-BA can reduce insomnia and depressive symptoms as well as the daily dose of hypnotic medication in patients with chronic insomnia resistant to pharmacological treatment.",
keywords = "Behavioural analysis, Cognitive behavioural therapy, Hypnotics, Insomnia, Treatment-resistant",
author = "Isa Okajima and Masaki Nakamura and Shingo Nishida and Akira Usui and Hayashida, {Ken ichi} and Meri Kanno and Shun Nakajima and Yuichi Inoue",
year = "2013",
month = "12",
day = "15",
doi = "10.1016/j.psychres.2013.06.028",
language = "English",
volume = "210",
pages = "515--521",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Cognitive behavioural therapy with behavioural analysis for pharmacological treatment-resistant chronic insomnia

AU - Okajima, Isa

AU - Nakamura, Masaki

AU - Nishida, Shingo

AU - Usui, Akira

AU - Hayashida, Ken ichi

AU - Kanno, Meri

AU - Nakajima, Shun

AU - Inoue, Yuichi

PY - 2013/12/15

Y1 - 2013/12/15

N2 - This study aimed to determine whether (1) cognitive behavioural therapy with behavioural analysis for insomnia (CBTi-BA) is more effective for insomnia and co-morbid depressive symptoms than treatment as usual (TAU) and (2) whether CBTi-BA promotes earlier reduction of the daily dose of hypnotic medication in chronic insomnia resistant to pharmacological treatment. A total of 63 patients with chronic insomnia aged 20-77 years who already received hypnotic medication regularly were assigned to two interventions: combined therapy or TAU alone. The subjects provided demographic information and completed self-rating scales for insomnia and depressive symptoms. After treatment, the combined therapy group showed significant decreases in the symptoms of both insomnia and depression and significant reductions in the daily dose of hypnotic medication compared with the group receiving TAU alone. In the combined therapy group, 71% of the participants reported a reduction in insomnia to normal levels and 79% succeeded in decreasing the daily dose of hypnotics to 50% or less of the baseline dose. These results revealed that CBTi-BA can reduce insomnia and depressive symptoms as well as the daily dose of hypnotic medication in patients with chronic insomnia resistant to pharmacological treatment.

AB - This study aimed to determine whether (1) cognitive behavioural therapy with behavioural analysis for insomnia (CBTi-BA) is more effective for insomnia and co-morbid depressive symptoms than treatment as usual (TAU) and (2) whether CBTi-BA promotes earlier reduction of the daily dose of hypnotic medication in chronic insomnia resistant to pharmacological treatment. A total of 63 patients with chronic insomnia aged 20-77 years who already received hypnotic medication regularly were assigned to two interventions: combined therapy or TAU alone. The subjects provided demographic information and completed self-rating scales for insomnia and depressive symptoms. After treatment, the combined therapy group showed significant decreases in the symptoms of both insomnia and depression and significant reductions in the daily dose of hypnotic medication compared with the group receiving TAU alone. In the combined therapy group, 71% of the participants reported a reduction in insomnia to normal levels and 79% succeeded in decreasing the daily dose of hypnotics to 50% or less of the baseline dose. These results revealed that CBTi-BA can reduce insomnia and depressive symptoms as well as the daily dose of hypnotic medication in patients with chronic insomnia resistant to pharmacological treatment.

KW - Behavioural analysis

KW - Cognitive behavioural therapy

KW - Hypnotics

KW - Insomnia

KW - Treatment-resistant

UR - http://www.scopus.com/inward/record.url?scp=84886953239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886953239&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2013.06.028

DO - 10.1016/j.psychres.2013.06.028

M3 - Article

C2 - 23953170

AN - SCOPUS:84886953239

VL - 210

SP - 515

EP - 521

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

IS - 2

ER -